Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
40.96
0.00 (0.00%)
May 4, 2026, 10:25 AM EDT - Market open
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $5.24 billion as of May 4, 2026. Its market cap has increased by 130.03% in one year.
Market Cap
5.24B
Enterprise Value
5.25B
1-Year Change
130.03%
Ranking
Category
Stock Price
$40.96
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.10M to $5.24B, an increase of 658.67%. That is a compound annual growth rate of 27.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 5.24B | 64.74% |
| Dec 31, 2025 | 3.18B | -19.93% |
| Dec 31, 2024 | 3.97B | -44.04% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 38.54% |
| Dec 31, 2021 | 4.13B | -4.73% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | 1.96B | 163.72% |
| Dec 31, 2018 | 741.80M | -32.09% |
| Dec 29, 2017 | 1.09B | 58.05% |
| Nov 9, 2017 | 691.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 5.60B |
| Rhythm Pharmaceuticals | 5.59B |
| Scholar Rock Holding | 5.53B |
| Corcept Therapeutics | 5.52B |
| Immunovant | 5.52B |
| Xenon Pharmaceuticals | 5.42B |
| PTC Therapeutics | 5.40B |
| Caris Life Sciences | 5.22B |